Updated:
Meltwind Advisory
Meltwind Advisory LLP are the due diligence and portfolio management team for Jonathan Milner, founder and former CEO of Abcam. Jonathan invests as an Angel...
Meltwind Advisory
Meltwind Advisory LLP are the due diligence and portfolio management team for Jonathan Milner, founder and former CEO of Abcam. Jonathan invests as an Angel across the life sciences, supporting early-stage companies throughout their journey with investment and guidance.
General information
Firm type
Single Family Office
Year founded
2014
AUM
Undisclosed
Location
Region
Europe
Country
United Kingdom
City
Cambridge
Corporate office
Cambridge, UK
Principals
Jonathan Milner
CEO & Executive Director
Mike Murphy
Portfolio Manager
Ellisa Osborne
Executive Assistant
Sector focus
Frequently asked questions
Who makes investment decisions at Meltwind Advisory?
Jonathan Milner serves as CEO and Executive Director and is the ultimate decision-maker for all investments. Mike Murphy acts as Portfolio Manager, handling ongoing due diligence and portfolio-company monitoring. The firm identifies Milner as the sole capital source, so investment approvals run through him.
How does Meltwind source deals in life sciences?
Meltwind draws on Jonathan Milner's network built over more than two decades as founder and CEO of Abcam, a global life-science tools company. The firm targets Series A and Series B rounds in tools and platform therapeutics, deal stages where Milner's operating experience can evaluate scientific and commercial viability more accurately than a generalist investor.
Is Meltwind a single-family office or an asset manager?
Legally structured as an LLP, Meltwind Advisory functions as a single-family office. It manages the personal capital of Jonathan Milner and discloses no outside limited partners. The firm's team handles due diligence and portfolio management exclusively for Milner's direct investments.
Does Meltwind invest in fund commitments or only direct deals?
Meltwind's stated focus is direct investments into early-stage companies. The firm's website describes a mandate for Series A and Series B life science tools and platform therapeutics companies, with no mention of fund commitments or allocations to external venture funds.
Where does Meltwind's underlying capital come from?
Jonathan Milner founded Abcam, a biological-reagent supplier, and grew it into a publicly traded company before stepping away as CEO. He channels the resulting personal wealth into Meltwind Advisory, giving the firm a concentrated pool of capital derived entirely from life-science entrepreneurship.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: